Skip to Content

Gentaur Nivolumab – Anti-PD-1 Antibody

A research-grade biosimilar to nivolumab, targeting PD-1. Used in tumor immunology, TIL analysis, and immune modulation.
1,234,567.00 € 1,234,567.00 €

0.00 € / Units
Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days